<DOC>
	<DOCNO>NCT02741154</DOCNO>
	<brief_summary>study effect aromataze inhibitor induction together short stimulation protocol gonadotrphin release hormon antagonist case expect poor responder ICSI</brief_summary>
	<brief_title>Role Aromatase Inhibitor Enhance Ovulation Poor Responder During Induction With Short Antagonist Protocol Cases ICSI</brief_title>
	<detailed_description>This prospective randomized case control study conduct Maternity hospital IVF unite Minia University approve local ethical committee obstetrics gynecology department faculty medicine , study detail explain patient informed consent obtain inclusion study . enrol patient randomize two group use simple randomization seal opaque envelops contain serial computer generate number Control group receive HMG 300 IU daily start first day menses follow trans vaginal ultrasound ( TVUS ) least three follicle reach 14mm diameter GnRh antagonist give 0.1 ml continue follow least three follicle reach 17mm diameter ovum pickup do TVUS guide less three follicle cycle cancel . Study group receive management plus letrozole 2.5mg daily start first day menses 5 day continue protocol</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>infertlity indicate ICSI Ovarian factor Tubal factor Unexplained infertility poor responder Expected high responder Endometriosis Male uterine factor Ovarian mass cyst</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>aromataze inhibitor , poor responder , induction</keyword>
</DOC>